MRI Reveals Cardiac Involvement in Recovered COVID-19 Patients
By MedImaging International staff writers Posted on 05 Aug 2020 |
Cardiovascular Magnetic Resonance (CMR) imaging reveals cardiac involvement and myocardial inflammation in recently recovered COVID-19 patients, claims a new study.
Researchers at University Hospital Frankfurt (Germany), the German Centre for Cardiovascular Research (DZHK; Berlin, Germany), and other institutions conducted a study in 100 patients (53% male, median age 49 years) recently recovered from COVID-19 in order to evaluate the presence of myocardial injury. Demographic characteristics, cardiac blood markers, and CMR imaging were obtained and compared with age-matched and sex-matched control groups of healthy volunteers and risk factor–matched patients.
The results revealed that at the time of CMR, high-sensitivity troponin T was detectable in 71% of the patients recently recovered from COVID-19, and significantly elevated in five of them. Compared with healthy controls and risk factor–matched controls, patients recently recovered from COVID-19 had lower left ventricular ejection fraction, higher left ventricle volumes, and higher left ventricle mass. In all, 78% of recently recovered patients had abnormal CMR findings, such as raised myocardial native T1, raised myocardial native T2, myocardial late gadolinium enhancement, and pericardial enhancement.
High-sensitivity troponin T was significantly correlated with native T1 and native T2 mapping. There was a small but significant difference between patients who recovered at home versus those recovering in a hospital for native T1 mapping, but not for native T2 mapping or high-sensitivity troponin T levels. None of the measures were correlated with time from COVID-19 diagnosis. Endomyocardial biopsy in patients with severe findings revealed active lymphocytic inflammation. The study was published on July 27, 2020, in JAMA Cardiology.
“Native T1 and T2 were the measures with the best discriminatory ability to detect COVID-19–related myocardial pathology,” concluded lead author Valentina Puntmann, MD, PhD, of DZHK, and colleagues. “Our findings may provide an indication of potentially considerable burden of inflammatory disease in large and growing parts of the population, and urgently require confirmation in a larger cohort.”
Cardiac MRI is an imaging technology for the non-invasive assessment of the function and structure of the cardiovascular system based on the same basic principles as magnetic resonance imaging (MRI), with optimizations that use rapid imaging sequences. As a result, CMR images are currently acquired in steps. Patients breathe in and then hold their breath for each image, then recover before repeating the process for the next image.
Related Links:
University Hospital Frankfurt
German Centre for Cardiovascular Research
Researchers at University Hospital Frankfurt (Germany), the German Centre for Cardiovascular Research (DZHK; Berlin, Germany), and other institutions conducted a study in 100 patients (53% male, median age 49 years) recently recovered from COVID-19 in order to evaluate the presence of myocardial injury. Demographic characteristics, cardiac blood markers, and CMR imaging were obtained and compared with age-matched and sex-matched control groups of healthy volunteers and risk factor–matched patients.
The results revealed that at the time of CMR, high-sensitivity troponin T was detectable in 71% of the patients recently recovered from COVID-19, and significantly elevated in five of them. Compared with healthy controls and risk factor–matched controls, patients recently recovered from COVID-19 had lower left ventricular ejection fraction, higher left ventricle volumes, and higher left ventricle mass. In all, 78% of recently recovered patients had abnormal CMR findings, such as raised myocardial native T1, raised myocardial native T2, myocardial late gadolinium enhancement, and pericardial enhancement.
High-sensitivity troponin T was significantly correlated with native T1 and native T2 mapping. There was a small but significant difference between patients who recovered at home versus those recovering in a hospital for native T1 mapping, but not for native T2 mapping or high-sensitivity troponin T levels. None of the measures were correlated with time from COVID-19 diagnosis. Endomyocardial biopsy in patients with severe findings revealed active lymphocytic inflammation. The study was published on July 27, 2020, in JAMA Cardiology.
“Native T1 and T2 were the measures with the best discriminatory ability to detect COVID-19–related myocardial pathology,” concluded lead author Valentina Puntmann, MD, PhD, of DZHK, and colleagues. “Our findings may provide an indication of potentially considerable burden of inflammatory disease in large and growing parts of the population, and urgently require confirmation in a larger cohort.”
Cardiac MRI is an imaging technology for the non-invasive assessment of the function and structure of the cardiovascular system based on the same basic principles as magnetic resonance imaging (MRI), with optimizations that use rapid imaging sequences. As a result, CMR images are currently acquired in steps. Patients breathe in and then hold their breath for each image, then recover before repeating the process for the next image.
Related Links:
University Hospital Frankfurt
German Centre for Cardiovascular Research
Latest MRI News
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
- First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
- New Model Improves Comparison of MRIs Taken at Different Institutions
- Groundbreaking New Scanner Sees 'Previously Undetectable' Cancer Spread
- First-Of-Its-Kind Tool Analyzes MRI Scans to Measure Brain Aging
- AI-Enhanced MRI Images Make Cancerous Breast Tissue Glow
- AI Model Automatically Segments MRI Images
- New Research Supports Routine Brain MRI Screening in Asymptomatic Late-Stage Breast Cancer Patients
- Revolutionary Portable Device Performs Rapid MRI-Based Stroke Imaging at Patient's Bedside
- AI Predicts After-Effects of Brain Tumor Surgery from MRI Scans
- MRI-First Strategy for Prostate Cancer Detection Proven Safe
- First-Of-Its-Kind 10' x 48' Mobile MRI Scanner Transforms User and Patient Experience
- New Model Makes MRI More Accurate and Reliable
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more